We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDC icon
201
Belden
BDC
$5.28B
$2.25M 0.11%
32,572
+16,300
+100% +$1.25M
WR
202
DELISTED
Westar Energy Inc
WR
$2.23M 0.11%
42,507
ZBRA icon
203
Zebra Technologies
ZBRA
$17.9B
$2.21M 0.11%
15,915
+125
+0.8% +$16K
TYL icon
204
Tyler Technologies
TYL
$13B
$2.21M 0.11%
10,490
+95
+0.9% +$19K
IJR icon
205
iShares Core S&P Small-Cap ETF
IJR
$112B
$2.2M 0.11%
28,570
+545
+2% +$42.4K
PSX icon
206
Phillips 66
PSX
$86B
$2.18M 0.1%
22,724
-3,826
-14% -$372K
CBSH icon
207
Commerce Bancshares
CBSH
$8.41B
$2.17M 0.1%
53,534
-443
-0.8% -$17.6K
TKR icon
208
Timken Company
TKR
$8.77B
$2.17M 0.1%
47,626
-6,960
-13% -$335K
CRL icon
209
Charles River Laboratories
CRL
$13.2B
$2.17M 0.1%
20,315
-1,941
-9% -$209K
LPX icon
210
Louisiana-Pacific
LPX
$5.2B
$2.17M 0.1%
75,267
+19,500
+35% +$559K
QQQ icon
211
Invesco QQQ Trust
QQQ
$479B
$2.16M 0.1%
13,500
-3,900
-22% -$644K
EHC icon
212
Encompass Health
EHC
$12.4B
$2.16M 0.1%
+47,494
New +$2.04M
PTEN icon
213
Patterson-UTI
PTEN
$4.19B
$2.15M 0.1%
122,786
-14,500
-11% -$303K
AVNT icon
214
Avient
AVNT
$4.19B
$2.12M 0.1%
49,920
-5,112
-9% -$221K
EIX icon
215
Edison International
EIX
$26.1B
$2.12M 0.1%
33,307
-6,016
-15% -$371K
ULTI
216
DELISTED
Ultimate Software Group Inc
ULTI
$2.11M 0.1%
8,644
+153
+2% +$36.1K
CTLT
217
DELISTED
CATALENT, INC.
CTLT
$2.1M 0.1%
51,163
SHW icon
218
Sherwin-Williams
SHW
$88.1B
$2.1M 0.1%
16,071
-1,356
-8% -$185K
KRC icon
219
Kilroy Realty
KRC
$4.32B
$2.09M 0.1%
29,411
WRB icon
220
W.R. Berkley
WRB
$26.3B
$2.09M 0.1%
96,893
WAB icon
221
Wabtec
WAB
$49.7B
$2.08M 0.1%
25,597
SCI icon
222
Service Corp International
SCI
$11.4B
$2.08M 0.1%
55,059
-1,197
-2% -$46K
RNR icon
223
RenaissanceRe
RNR
$13.2B
$2.07M 0.1%
14,929
+2,341
+19% +$304K
GXP
224
DELISTED
Great Plains Energy Incorporated
GXP
$2.05M 0.1%
64,520
MDP
225
DELISTED
Meredith Corporation
MDP
$2.05M 0.1%
38,073
+6,300
+20% +$374K

Similar funds

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.